Skip to content

← All news

Policy

UK regulator suspends Amgen rare-disease drug Tavneos for new patients

1 source ·1 article ·Sep 1, 15:57 UTC Amgen

Covered by 1 outlet

All coverage · 1 article

Investing.com Stock Market ·Sep 1, 15:57 UTC

UK regulator suspends Amgen rare-disease drug Tavneos for new patients